PROBLEM TO BE SOLVED: To provide a pharmaceutical preparation for treating skeletal muscle diseases, particularly diseases such as bone or joint diseases. A pharmaceutical preparation comprising solvent / surfactant-treated plasma (S / D plasma) and hyaluronic acid or a salt thereof, which further comprises divalent calcium ions (Ca2 +) and is about 0.10 mg / A pharmaceutical formulation comprising hyaluronic acid or a salt thereof at a concentration in the range of ml to about 200 mg / ml. Said pharmaceutical preparation, which is configured for parenteral administration, preferably for intraosseous, periosteal, intraarticular or periarticular administration or for intratendon, peritendon, intraligamental or periberal administration. Said pharmaceutical preparation for use in the treatment of bone or joint diseases. [Selection diagram] None【課題】骨格筋疾患、特に骨又は関節疾患のような疾患を処置するための医薬製剤の提供。【解決手段】溶剤／界面活性剤処理された血漿（Ｓ／Ｄ血漿）とヒアルロン酸又はその塩とを含む医薬製剤であって、二価カルシウムイオン（Ｃａ２＋）をさらに含み、約０．１０ｍｇ／ｍｌ～約２００ｍｇ／ｍｌの範囲の濃度でヒアルロン酸又はその塩を含む、医薬製剤。非経口投与用、好ましくは、骨内、骨周囲、関節内若しくは関節周囲投与用又は腱内、腱周囲、靭帯内若しくは靭帯周囲投与用に構成されている、前記医薬製剤。骨疾患又は関節疾患の処置における使用のための、前記医薬製剤。【選択図】なし
